Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that causes infectious respiratory disease, named as coronavirus disease of 2019 (COVID-19). While extensive studies have provided basic information on clinical characteristics of COVID-19, the disease pathology is not fully known. The SARS-CoV-2 virus structural studies and biochemical experiments have also indicated that the virus receptor-binding domain (RBD) binds with a high affinity to angiotensin-converting enzyme-2 (ACE-2) receptor from humans; however, the mechanism remains unclear. Hereunder, a summary of relevant findings in the SARS-CoV-2 virus pathology and major pathogenicity mechanisms are discussed. This review of studies provides additional enlightenments on the way forward to prevent further spread or even cure for the SARS-CoV-2 virus-caused COVID-19 disease, either-or should a similar viral plague occur in the future.
Impact statement
The current survey of studies outlines the direct and indirect effects of SARS-CoV-2 on the specific body systems and summarizes the SARS-CoV-2 main pathogenicity mechanisms that require attention during patient hospitalization and for further research.
World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020.
2.
ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZL.A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature2020;
579:270–3
3.
World Health Organization. SARS-CoV that caused the2002–2003 pandemic – 5 July 2003.
4.
CormanVMMuthDNiemeyerDDrostenC.Hosts and sources of endemic human coronaviruses. Adv Virus Res2018;
100:163–88
5.
GeXLiYYangXZhangHZhouPZhangYShiZ.Metagenomic analysis of viruses from bat fecal samples reveals many novel viruses in insectivorous bats in China. J Virol2012;
86:4620–30
6.
GeXYLiJLYangXLChmuraAAZhuGEpsteinJHMazetJKHuBZhangWPengCZhangYJLuoCMTanBWangNZhuYCrameriGZhangSYWangLFDaszakPShiZL.Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature2013;
503:535–8
7.
MarraMAJonesSJAstellCRHoltRABrooks-WilsonAButterfieldYSKhattraJAsanoJKBarberSAChanSYCloutierACoughlinSMFreemanDGirnNGriffithOLLeachSRMayoMMcDonaldHMontgomerySBPandohPKPetrescuASRobertsonAGScheinJESiddiquiASmailusDEStottJMYangGSPlummerFAndonovAArtsobHBastienNBernardKBoothTFBownessDCzubMDrebotMFernandoLFlickRGarbuttMGrayMGrollaAJonesSFeldmannHMeyersAKabaniALiYNormandSStroherUTipplesGATylerSVogrigRWardDWatsonBBrunhamRCKrajdenMPetricMSkowronskiDMUptonCRoperRL.The genome sequence of the SARS-associated coronavirus. Science2003;
300:1399–404
8.
International Committee on Taxonomy of Viruses. Naming the 2019 Coronavirus – 5 February 2020.
9.
YuFDuLOjciusDMPanCJiangS.Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect2020;
22:74–9
10.
KakimotoKKamiyaHYamagishiTMatsuiTSuzukiMWakitaT.Initial investigation of transmission of COVID-19 among crew members during quarantine of a cruise ship – Yokohama, Japan, February 2020. MMWR Morb Mortal Wkly Rep2020;
69:312–3
11.
HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXChengZYuTXiaJWeiYWuWXieXYinWLiHLiuMXiaoYGaoHGuoLXieJWangGJiangRGaoZJinQWangJCaoB.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet2020;
395:497–506
12.
GuanWJNi ZYHuYLiang WHOu CQHe JXLiuLShanHLeiCLHuiDSCDuBLi LJZengGYuen KYChen RCTangCLWangTChen PY, XiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiu SQLuoJYeCJZhuSYZhongNS.Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med2020;
382:1708–1720
13.
WuZMcGooganJM.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA2020;
14.
YangJZhengYGouXPuKChenZGuoQ, JRWangHWangYZhouY.Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and Meta-analysis. Int J Infect Dis2020;
94:91–95
15.
ZhouFYuTDuRFanGLiuYLiuZXiangJWangYSongBGuXGuanLWeiYLiHWuXXuJTuSZhangYChenHCaoB.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet2020;
395:1054–62
16.
BaiYYaoLWeiTTianFJinDYChenLWangM.Presumed asymptomatic carrier transmission of COVID-19. JAMA2020;
323:1406–1407
17.
RotheCSchunkMSothmannPBretzelGFroeschlGWallrauchCZimmerTThielVJankeCGuggemosWSeilmaierMDrostenCVollmarPZwirglmaierKZangeSWolfelRHoelscherM.Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med2020;
382:970–1
18.
Nikolich-ZugichJKnoxKSRiosCTNattBBhattacharyaDFainMJ.SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience2020;
42:505–514
19.
YiYLagnitonPNPYeSLiEXuRH.COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci2020;
16:1753–66
20.
XuZShiLWangYZhangJHuangLZhangCLiuSZhaoPLiuHZhuLTaiYBaiCGaoTSongJXiaPDongJZhaoJWangFS.Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med2020;
8:420–2
21.
ChenNZhouMDongXQuJGongFHanYQiuYWangJLiuYWeiYXiaJYuTZhangXZhangL.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet2020;
395:507–13
22.
LiXWangLYanSYangFXiangLZhuJShenBGongZ.Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis2020;
94:128–132
23.
ShiSQinMShenBCaiYLiuTYangFGongWLiuXLiangJZhaoQHuangHYangBHuangC.Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol2020;e200950
24.
WangDHuBHuCZhuFLiuXZhangJWangBXiangHChengZXiongYZhaoYLiYWangXPengZ.Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. Jama2020;
323:1061–1069
25.
YangXYuYXuJShuHXiaJLiuHWuYZhangLYuZFangMYuTWangYPanSZouXYuanSShangY.Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med2020;
8:475–481
26.
Suxin WanQYFanSLvJZhangXGuoLLangCXiaoQXiaoKYiZQiangMXiangJZhangBChenY. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv 2020;
27.
XiaoFTangMZhengXLiuYLiXShanH. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology2020;
158:1831–1833
28.
HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHSpittersCEricsonKWilkersonSTuralADiazGCohnAFoxLPatelAGerberSIKimLTongSLuXLindstromSPallanschMAWeldonWCBiggsHMUyekiTMPillaiSK.Washington state-nCo VCIT. First case of 2019 novel coronavirus in the United States. N Engl J Med2020;
382:929–36
29.
WuYGuoCTangLHongZZhouJDongXYinHXiaoQTangYQuXKuangLFangXMishraNLuJShanHJiangGHuangX.Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol2020;
5:434–5
30.
ChengYLuoRWangKZhangMWangZDongLLiJYaoYGeSXuG.Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int2020;
97:829–838
31.
LushinaNKuoJSShaikhHA.Pulmonary, cerebral, and renal thromboembolic disease associated with COVID-19 infection. Radiology2020;201623
32.
ZhuLXuXMaKYangJGuanHChenSChenZChenG.Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant2020;
20:1859–1863
33.
Hua SuMYWanCYiL-XTangFZhuH-YYiFYangH-CFogoABNieXZhangC. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int2020; https://doiorg/101016/jkint202004003
34.
Ling MaWXLiDShiLMaoYXiongYZhangYZhangM. Effect of SARS-CoV-2 infection upon male gonadal function: a single centerbased study. medRxivhttps://doiorg/101101/2020032120037267 2020;
35.
FavalliEGIngegnoliFDe LuciaOCincinelliGCimazRCaporaliR.COVID-19 infection and rheumatoid arthritis: faraway, so close!Autoimmun Rev2020;
19:102523
36.
LinLLuLCaoWLiT.Hypothesis for potential pathogenesis of SARS-CoV-2 infection – a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect2020;
9:727–32
37.
ChenCZhangXRJuZYHeWF.Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi2020;
36:E005
38.
GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanY.The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res2020;
7:11
39.
MehtaPMcAuleyDFBrownMSanchezETattersallRSMansonJJ.Hlh across speciality collaboration UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet2020;
395:1033–4
40.
MoriguchiTHariiNGotoJHaradaDSugawaraHTakaminoJUenoMSakataHKondoKMyoseNNakaoATakedaMHaroHInoueOSuzuki-InoueKKubokawaKOgiharaSSasakiTKinouchiHKojinHItoMOnishiHShimizuTSasakiYEnomotoNIshiharaHFuruyaSYamamotoTShimadaS.A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis2020;
94:55–8
41.
WangYWangYChenYQinQ.Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol2020;
92:568–576
42.
FanZChenLLiJChengXJingmaoYTianCZhangYHuangSLiuZChengJ.Clinical features of COVID-19-related liver damage. Clin Gastroenterol Hepatol2020;
18:1561–1566
43.
ZhaoDYaoFWangLZhengLGaoYYeJGuoFZhaoHGaoR.A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis2020;
44.
PatelRBabadyETheelESStorchGAPinskyBASt GeorgeKSmithTCBertuzziS.Report from the American society for microbiology COVID-19 international summit. Value of diagnostic testing for SARS-CoV-2/COVID-19. mBio2020;
11:e00722-20
45.
World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases – 19 March 2020. 2020;WHO/COVID-19/laboratory/2020.5
46.
LiuWLiuLKouGZhengYDingYNiWWangQTanLWuWTangSXiongZZhengS.Evaluation of nucleocapsid and spike protein-based ELISAs for detecting antibodies against SARS-CoV-2. J Clin Microbiol2020;
58:e00461–20
47.
LiHLiuSMYuXHTangSLTangCK.Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents2020;
55:105951
48.
ChungMBernheimAMeiXZhangNHuangMZengXCuiJXuWYangYFayadZAJacobiALiKLiSShanH.CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology2020;
295:202–7
49.
ShiHHanXZhengC.Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China. Radiology2020;
295:20
50.
QinCLiuFYenTCLanX. (
18)F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging2020;
47:1281–6
51.
XuXYuCQuJZhangLJiangSHuangDChenBZhangZGuanWLingZJiangRHuTDingYLinLGanQLuoLTangXLiuJ.Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging2020;
47:1275–80
52.
DingYWangHShenHLiZGengJHanHCaiJLiXKangWWengDLuYWuDHeLYaoK.The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol2003;
200:282–9
53.
NgDLAl HosaniFKeatingMKGerberSIJonesTLMetcalfeMGTongSTaoYAlamiNNHaynesLMMuteiMAAbdel-WarethLUyekiTMSwerdlowDLBarakatMZakiSR.Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol2016;
186:652–8
54.
ZuZYJiangMDXuPPChenWNiQQLuGMZhangLJ. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology2020: 200490
55.
LuoWY, HGouJLiXSunYLiJLiuL. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints 2020, 2020020407 2020;
56.
SheahanTMorrisonTEFunkhouserWUematsuSAkiraSBaricRSHeiseMT.MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog2008;
4:e1000240
57.
Ben AddiALefortAHuaXLibertFCommuniDLedentCMacoursPTilleySLBoeynaemsJMRobayeB.Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. Eur J Immunol2008;
38:1610–20
58.
ZustRCervantes-BarraganLHabjanMMaierRNeumanBWZiebuhrJSzretterKJBakerSCBarchetWDiamondMSSiddellSGLudewigBThielV.Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol2011;
12:137–43
59.
HuangKJSuIJTheronMWuYCLaiSKLiuCCLeiHY.An interferon-gamma-related cytokine storm in SARS patients. J Med Virol2005;
75:185–94
60.
RockxBBaasTZornetzerGAHaagmansBSheahanTFriemanMDyerMDTealTHProllSvan den BrandJBaricRKatzeMG.Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol2009;
83:7062–74
61.
LiuKFangYYDengYLiuWWangMFMaJPXiaoWWangYNZhongMHLi CHLiGCLiuHG.Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl)2020;
133:1025–1031
62.
LuXZhangLDuHZhangJLiYYQuJZhangWWangYBaoSLiYWuCLiuHLiuDShaoJPengXYangYLiuZXiangYZhangFSilvaRMPinkertonKEShenKXiaoHXuSWongGWK.Chinese pediatric novel coronavirus study T. SARS-CoV-2 infection in children. N Engl J Med2020;
382:1663–5
63.
ShiHHanXJiangNCaoYAlwalidOGuJFanYZhengC.Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis2020;
20:425–34
64.
XuXWWuXXJiangXGXuKJYingLJMaCLLiSBWangHYZhangSGaoHNShengJFCaiHLQiuYQLiLJ.Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ2020;
368:m606
65.
ZhangJJDongXCaoYYYuanYDYangYBYanYQAkdisCAGaoYD.Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy2020;
66.
PeirisJSChuCMChengVCChanKSHungIFPoonLLLawKITangBSHonTYChanCSChanKHNgJSZhengBJNgWLLaiRWGuanYYuenKY; Group HUSS.
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet2003;
361:1767–72
67.
ChanJFLauSKToKKChengVCWooPCYuenKY.Middle east respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev2015;
28:465–522
68.
ChuKHTsangWKTangCSLamMFLaiFMToKFFungKSTangHLYanWWChanHWLaiTSTongKLLaiKN.Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int2005;
67:698–705
69.
AlsaadKOHajeerAHAl BalwiMAl MoaiqelMAl OudahNAl AjlanAAlJohaniSAlsolamySGmatiGEBalkhyHAl-JahdaliHHBaharoonSAArabiYM.Histopathology of Middle east respiratory syndrome coronovirus (MERS-CoV) infection – clinicopathological and ultrastructural study. Histopathology2018;
72:516–24
70.
DingYHeLZhangQHuangZCheXHouJWangHShenHQiuLLiZGengJCaiJHanHLiXKangWWengDLiangPJiangS.Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol2004;
203:622–30
71.
XuJQiLChiXYangJWeiXGongEPehSGuJ.Orchitis: a complication of severe acute respiratory syndrome (SARS. ). Biol Reprod2006;
74:410–6
72.
QiuLLiuXXiaoMXieJCaoWLiuZMorseAXieYLiTZhuL.SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection. Clin Infect Dis2020;ciaa375
73.
ChenHGuoJWangCLuoFYuXZhangWLiJZhaoDXuDGongQLiaoJYangHHouWZhangY.Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet2020;
395:809–15
74.
StockmanLJBellamyRGarnerP.SARS: systematic review of treatment effects. PLoS Med2006;
3:e343
75.
ArabiYMMandourahYAl-HameedFSindiAAAlmekhlafiGAHusseinMAJoseJPintoRAl-OmariAKharabaAAlmotairiAAl KhatibKAlraddadiBShalhoubSAbdulmomenAQushmaqIMadyASolaimanOAl-AithanAMAl-RaddadiRRagabABalkhyHHAl HarthyADeebAMAl MutairiHAl-DawoodAMersonLHaydenFGFowlerRA.Saudi Critical care trial G.
Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med2018;
197:757–67
76.
ElstonDM.Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic. J Am Acad Dermatol2020;
82:1085–6
77.
YanYChenHChenLChengBDiaoPDongLGaoXGuHHeLJiCLaiJHLeiWLiTLiLLiLLiuRLiuDLuWShiQSongYTaoJWangJWangBWuGXiangYXieLXuJYaoJZhangZZhangFZhongJLiSLiH.H. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease.Dermatol Ther2019;
2020:e13310
78.
DesforgesMLe CoupanecADubeauPBourgouinALajoieLDubeMTalbotPJ.Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the Central nervous system?Viruses2019;
12:14
79.
HwangCS.Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan2006;
15:26–8
80.
TsaiLKHsiehSTChaoCCChenYCLinYHChangSCChangYC.Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol2004;
61:1669–73
81.
HungECChimSSChanPKTongYKNgEKChiuRWLeungCBSungJJTamJSLoYM.Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem2003;
49:2108–9
82.
LauKKYuWCChuCMLauSTShengBYuenKY.Possible Central nervous system infection by SARS coronavirus. Emerging Infect Dis2004;
10:342–4
83.
SaadMOmraniASBaigKBahloulAElzeinFMatinMASelimMAAl MutairiMAl NakhliDAl AidaroosAYAl SherbeeniNAl-KhashanHIMemishZAAlbarrakAM.Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis2014;
29:301–6
84.
McCrayPBJrPeweLWohlford-LenaneCHickeyMManzelLShiLNetlandJJiaHPHalabiCSigmundCDMeyerholzDKKirbyPLookDCPerlmanS.Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol2007;
81:813–21
85.
NetlandJMeyerholzDKMooreSCassellMPerlmanS.Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol2008;
82:7264–75
86.
LiKWohlford-LenaneCPerlmanSZhaoJJewellAKReznikovLRGibson-CorleyKNMeyerholzDKMcCrayPB.Jr.Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis2016;
213:712–22
87.
MaoLJinHWangMHuYChenSHeQChangJHongCZhouYWangDMiaoXLiYHuB.Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol2020;
77:683–690
88.
CaiQHuangDOuPYuHZhuZXiaZSuYMaZZhangYLiZHeQLiuLFuYChenJ.COVID-19 in a designated infectious diseases hospital outside Hubei province, China. Allergy2020;
395:497–506
89.
WallsACPark Yj Tortorici Ma WallAMcGuireAtVeeslerD.Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell2020;
181:281–292
90.
WanYShangJGrahamRBaricRSLiF.Receptor recognition by the novel coronavirus from Wuhan: an analysis based on Decade-Long structural studies of SARS coronavirus. J Virol2020;
94:e00127–20
91.
WrappDWangNCorbettKSGoldsmithJAHsiehCLAbionaOGrahamBSMcLellanJS.Cryo-EM structure of the 2019-nCoV spike in the perfusion conformation. Science2020;
367:1260–3
92.
LetkoMMarziAMunsterV.Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol2020;
5:562–9
93.
GlowackaIBertramSMullerMAAllenPSoilleuxEPfefferleSSteffenITsegayeTSHeYGnirssKNiemeyerDSchneiderHDrostenCPohlmannS.Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol2011;
85:4122–34
94.
HeurichAHofmann-WinklerHGiererSLiepoldTJahnOPohlmannS.TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol2014;
88:1293–307
95.
ShullaAHeald-SargentTSubramanyaGZhaoJPerlmanSGallagherT.A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol2011;
85:873–82
96.
Peng ZhouX-LYWangX-GHuBZhangLZhangWSiH-RZhuYLiBHuangC-LChenH-DChenJLuoYGuo JiangR-DLiuM-QChenYShenX-RWangXZhengX-SZhaoKChenQ-JDengFLiuL-LYanBZhanF-XWangY-YXiaoGShiZ-L. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv2020;
